Recap: Atreca Q1 Earnings
Atreca (NASDAQ:BCEL) reported its Q1 earnings results on Wednesday, May 11, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Benzinga ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
THE TRUTH ABOUT: Atreca | History Defined
HC Wainwright Sees 'Multiple Catalyst Opportunities' After Atreca Inks Licensing Pact With Zymeworks
Atreca Inc (NASDAQ:BCEL) announced a licensing agreement with Zymeworks Inc (NYSE:ZYME) to utilize their ZymeLink technology to develop novel antibody-drug conjugates (ADCs). The agreement includes a two-year research term for Atreca to evaluate antibodies as ADCs using ZymeLink with the option for a third year. Atreca can acquire three commercial licenses to develop three unique…
Benzinga ·
Earnings Preview For Atreca
Atreca (NASDAQ:BCEL) is set to give its latest quarterly earnings report on Thursday, 2022-03-03. Here's what investors need to know before the announcement.
Analysts estimate that Atreca will report an earnings per share (EPS) of $-0.75.
Benzinga ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
Benzinga
Organisations
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
